Tiago Fleming Outeiro

Cytowane przez

	Wszystkie	Od 2020
Cytowania	40232	19398
h-indeks	90	62
i10-indeks	269	244

4200

2100

1050

3150

20062007200820092010201120122013201420152016201720182019202020212022202320242025158 200 389 498 713 930 1082 1466 1873 2042 2335 2713 2914 3104 3433 4168 3820 3464 3694 798

Dostęp publiczny

Wyświetl wszystko

258 artykułów

34 artykuły

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Diana F. LázaroCenter for Neurodegenerative Disease Research, UPennZweryfikowany adres z pennmedicine.upenn.edu
Sandra TenreiroNova Medical School- Universidade NOVA de Lisboa, Lisbon, PortugalZweryfikowany adres z nms.unl.pt
Markus ZweckstetterGerman Center for Neurodegenerative Diseases (DZNE)Zweryfikowany adres z dzne.de
Hugo Vicente MirandaNOVA Medical School (NMS), New University of Lisbon (UNL)Zweryfikowany adres z nms.unl.pt
Flaviano GiorginiProfessor of Neurogenetics, University of LeicesterZweryfikowany adres z le.ac.uk
Bradley HymanMassachusetts General Hospital, Harvard Medical SchoolZweryfikowany adres z partners.org
Pamela McLeanMayo ClinicZweryfikowany adres z mayo.edu
Eva M. SzegoDept. Neurology, Technische Universität DresdenZweryfikowany adres z ukdd.de
Joaquim FerreiraFaculdade de Medicina, Universidade de LisboaZweryfikowany adres z medicina.ulisboa.pt
Johannes AttemsNewcastle UniveristyZweryfikowany adres z ncl.ac.uk
Luísa V. LopesPrincipal Investigator, iMM, Faculdade de Medicina, Universidade de LisboaZweryfikowany adres z medicina.ulisboa.pt
Federico HerreraFaculty of Sciences, University of Lisbon, Lisbon, PortugalZweryfikowany adres z fc.ul.pt
Jochen KluckenUniversity of Luxembourg, Centre Hospitalier du LuxembourgZweryfikowany adres z uni.lu
Tomás Lopes da FonsecaBayer AGZweryfikowany adres z allmaclong.com
Braus, GerhardProfessor for Microbiology and Genetics, University of GoettingenZweryfikowany adres z gwdg.de
Omar El-AgnafQatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar FoundationZweryfikowany adres z hbku.edu.qa
Joana Esteves CoelhoiMMLisboaZweryfikowany adres z medicina.ulisboa.pt
Luc BueeUniversité de LilleZweryfikowany adres z univ-lille.fr
Paul MuchowskiUCSFZweryfikowany adres z gladstone.ucsf.edu
Claudia Nunes dos SantosNOVA Medical School, Universidade Nova de LisboaZweryfikowany adres z nms.unl.pt

Obserwuj

Tiago Fleming Outeiro

University Medical Center Goettingen, Goettingen, Germany

Zweryfikowany adres z gwdg.de - Strona główna

Neurodegeneration Parkinson's disease Huntington's disease amyloid protein misfolding


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹ DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021	13606*	2021
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease TF Outeiro, E Kontopoulos, SM Altmann, I Kufareva, KE Strathearn, ... science 317 (5837), 516-519, 2007	1300	2007
Yeast cells provide insight into alpha-synuclein biology and pathobiology TF Outeiro, S Lindquist Science 302 (5651), 1772-1775, 2003	1040	2003
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells C Hansen, E Angot, AL Bergström, JA Steiner, L Pieri, G Paul, TF Outeiro, ... The Journal of clinical investigation 121 (2), 715-725, 2011	1002	2011
Formation of toxic oligomeric α-synuclein species in living cells TF Outeiro, P Putcha, JE Tetzlaff, R Spoelgen, M Koker, F Carvalho, ... PloS one 3 (4), e1867, 2008	539	2008
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein S Willingham, TF Outeiro, MJ DeVit, SL Lindquist, PJ Muchowski Science 302 (5651), 1769-1772, 2003	537	2003
SIRT1 and SIRT2: emerging targets in neurodegeneration G Donmez, TF Outeiro EMBO molecular medicine 5 (3), 344-352, 2013	472	2013
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ... Experimental neurology 213 (2), 315-325, 2008	464	2008
Dementia with Lewy bodies: an update and outlook TF Outeiro, DJ Koss, D Erskine, L Walker, M Kurzawa-Akanbi, D Burn, ... Molecular neurodegeneration 14, 1-18, 2019	414	2019
Alpha-synuclein: from secretion to dysfunction and death O Marques, TF Outeiro Cell death & disease 3 (7), e350-e350, 2012	401	2012
Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington’s and Parkinson’s diseases RA Bodner, TF Outeiro, S Altmann, MM Maxwell, SH Cho, BT Hyman, ... Proceedings of the National Academy of Sciences 103 (11), 4246-4251, 2006	348	2006
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation MJ Diógenes, RB Dias, DM Rombo, HV Miranda, F Maiolino, P Guerreiro, ... Journal of Neuroscience 32 (34), 11750-11762, 2012	315	2012
Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies A Villar‐Piqué, T Lopes da Fonseca, TF Outeiro Journal of neurochemistry 139, 240-255, 2016	312	2016
Protein phosphorylation in neurodegeneration: friend or foe? S Tenreiro, K Eckermann, TF Outeiro Frontiers in molecular neuroscience 7, 42, 2014	310	2014
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease M Martins, A Rosa, LC Guedes, BV Fonseca, K Gotovac, S Violante, ... PloS one 6 (10), e25443, 2011	309	2011
α-synuclein interacts with PrP^C to induce cognitive impairment through mGluR5 and NMDAR2B DG Ferreira, M Temido-Ferreira, H Vicente Miranda, VL Batalha, ... Nature neuroscience 20 (11), 1569-1579, 2017	301	2017
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super‐resolution microscopy KN Richter, NH Revelo, KJ Seitz, MS Helm, D Sarkar, RS Saleeb, E d'Este, ... The EMBO journal 37 (1), 139-159, 2018	295	2018
Emerging role of sirtuin 2 in the regulation of mammalian metabolism P Gomes, TF Outeiro, C Cavadas Trends in pharmacological sciences 36 (11), 756-768, 2015	261	2015
Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation DF Lázaro, EF Rodrigues, R Langohr, H Shahpasandzadeh, T Ribeiro, ... PLoS genetics 10 (11), e1004741, 2014	260	2014
Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro IL Derkatch, SM Uptain, TF Outeiro, R Krishnan, SL Lindquist, ... Proceedings of the National Academy of Sciences 101 (35), 12934-12939, 2004	259	2004

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy